These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25686394)

  • 1. Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.
    Goffredo P; Thomas SM; Dinan MA; Perkins JM; Roman SA; Sosa JA
    JAMA Intern Med; 2015 Apr; 175(4):638-40. PubMed ID: 25686394
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer.
    Al-Qurayshi Z; Bu Ali D; Srivastav S; Kandil E
    Oncology; 2017; 93(2):122-126. PubMed ID: 28609768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
    Marti JL; Davies L; Haymart MR; Roman BR; Tuttle RM; Morris LG
    Thyroid; 2015 Jul; 25(7):865-6. PubMed ID: 25963001
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer.
    Nixon IJ; Ganly I
    Future Oncol; 2013 Jul; 9(7):921-3. PubMed ID: 23837752
    [No Abstract]   [Full Text] [Related]  

  • 6. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
    Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
    Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid blocking policy--revisited.
    Solanki KK; Bomanji JB; Waddington WA; Ell PJ;
    Nucl Med Commun; 2004 Nov; 25(11):1071-6. PubMed ID: 15577583
    [No Abstract]   [Full Text] [Related]  

  • 8. The overuse of radioactive iodine in low-risk papillary thyroid cancer patients.
    Moten AS; Zhao H; Willis AI
    Surg Oncol; 2019 Jun; 29():184-189. PubMed ID: 31196486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
    Garcia A; Palmer BJ; Parks NA; Liu TH
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
    Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
    Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.
    Scott E; Learoyd D; Clifton-Bligh RJ
    Future Oncol; 2016 Nov; 12(22):2603-2613. PubMed ID: 27387641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.
    Sawka AM; Goldstein DP; Thabane L; Brierley JD; Tsang RW; Rotstein L; Kamalanathan S; Zhao B; Gafni A; Straus S; Ezzat S
    Endocr Pract; 2008 Mar; 14(2):175-84. PubMed ID: 18308655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.
    Sawka AM; Rotstein L; Brierley JD; Tsang RW; Thabane L; Gafni A; Straus S; Kamalanathan S; Zhao B; Goldstein DP; Rambaldini G; Ezzat S
    Thyroid; 2007 Dec; 17(12):1235-42. PubMed ID: 17988197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British Thyroid Association guidelines for the management of thyroid cancer in adults.
    Watkinson JC;
    Nucl Med Commun; 2004 Sep; 25(9):897-900. PubMed ID: 15319594
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
    Patel SS; Goldfarb M
    J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
    Rosario PW
    Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
    [No Abstract]   [Full Text] [Related]  

  • 18. Discussion.
    J Am Coll Surg; 2015 Apr; 220(4):625-7. PubMed ID: 25797748
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
    Kim DW
    Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioactive iodine 1311 (RAI) treatment. The nearest to the "magic bullet" but should always be preceded by a risk assessment, especially in the pediatric patient.
    Lubin E
    Pediatr Endocrinol Rev; 2011 Sep; 9(1):415-6. PubMed ID: 22783638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.